Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- Proteomic Alterations of HDL in Youth with Type 1 Diabetes: Outstanding Research at the Symposium
At the 2019 MedStar Health-Georgetown University Research Symposium, three abstracts were recognized... - Multi-Modal Sepsis Performance Improvement Initiative: Outstanding Research at the Symposium
At the 2019 MedStar Health-Georgetown University Research Symposium, three abstracts were recognized... - Recognizing Outstanding Resident and Fellow Research at the 2019 Research Symposium
On Thursday, May 30, approximately 1000 investigators, educators, innovators, and associates came to...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]